The rising prevalence of type 2 diabetes and obesity in these countries is increasing demand for effective GLP-1 agonist therapies
They are also being used to treat conditions including severe liver disease, sleep apnea and kidney disease

Hormone Replacement Therapy Bioidentical HRT and Hormone Pellets for Women and Men Women in perimenopause or menopause with hot flashes, night sweats, sleep changes, or vaginal dryness Women with low libido, mood changes, or brain fog confirmed by hormone testing Men with symptoms of low testosterone (fatigue, low libido, mood, body composition changes) plus lab confirmation GLP-1 Weight Loss Semaglutide Program with Weekly or Monthly Provider Support Adults with BMI of 30 or higher Adults with BMI of 27 or higher and at least one weight-related comorbidity such as hypertension, prediabetes, type 2 diabetes, or dyslipidemia Patients committed to weekly injections and provider check-ins HCG Diet Structured HCG Program for Targeted Fat Loss Adults seeking a structured, short-term, supervised weight loss framework Patients who have stalled on conventional diet and exercise approaches Those willing to follow a strict VLCD with weekly clinical check-ins IV Therapy FAQ Answers from our medical team 01 How long does an IV Therapy session take

The numbers: The subjects on semaglutide had an average change in weight of -13.7%, while those taking tirzepatide saw a decrease of -20.2%